Ilsung Pharmaceuticals Co., Ltd.
KRX:003120.KS
15910 (KRW) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||||||
| Net Income
| -20,940.893 | 105,241.192 | -1,367.51 | 3,220.257 | 6,718.55 | 2,945.529 | 2,628.653 | 3,017.242 | 98,853.931 | 4,034.564 | 7,955.018 | 36,451.736 | 35,083.007 | 6,297.465 | 8,049.787 | 34,163.059 | 17,699.848 |
| Depreciation & Amortization
| 2,849.033 | 3,094.045 | 3,073.84 | 3,058.734 | 3,084.872 | 3,013.352 | 3,227.452 | 3,021.584 | 2,761.475 | 2,811.633 | 3,202.13 | 3,280.697 | 3,239.945 | 3,391.852 | 3,194.235 | 3,847.303 | 1,494.369 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -19,483.422 | -44,572.965 | 3,818.028 | 2,454.8 | 1,195.829 | 9,560.907 | 3,778.231 | -6,510.458 | 364.752 | -2,216.99 | 1,153.788 | -2,475.569 | 2,309.194 | 9,422.889 | -14,692.913 | 3,236.134 | -12,368.069 |
| Accounts Receivables
| -7,001.551 | -3,791.557 | 619.953 | 2,126.237 | 3,536.904 | 6,554.556 | 1,575.803 | -259.497 | 782.188 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| -11,418.608 | -7,934.242 | 1,754.249 | 768.806 | -221.015 | 6,866.563 | -2,913.188 | -2,252.644 | -168.048 | 2,441.271 | -2,260.084 | 3,506.255 | -923.721 | 5,090.217 | -7,578.178 | -2,124.049 | -1,321.351 |
| Accounts Payables
| 684.315 | 4,386.648 | -1,341.84 | -225.301 | 31.058 | -2,950.625 | 4,063.48 | -280.904 | -276.387 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -1,747.578 | -37,233.814 | 2,785.666 | -214.942 | -2,151.118 | 2,694.344 | 6,691.419 | -4,257.814 | 532.8 | -4,658.261 | 3,413.872 | -5,981.824 | 3,232.915 | 4,332.672 | -7,114.735 | 5,360.183 | -11,046.718 |
| Other Non Cash Items
| -2,143.409 | -102,728.282 | 179.715 | -7,176.491 | -6,610.579 | -428.571 | 524.339 | -30,541.838 | -95,939.023 | -438.636 | -7,246.988 | -48,575.466 | -32,387.943 | -467.9 | 4,714.012 | -24,710.788 | -2,654.75 |
| Operating Cash Flow
| -39,718.692 | -38,966.011 | 5,704.073 | 1,557.299 | 4,388.673 | 15,091.217 | 10,158.675 | -31,013.47 | 6,041.135 | 4,190.571 | 5,063.948 | -11,318.602 | 8,244.203 | 18,644.306 | 1,265.121 | 16,535.708 | 4,171.398 |
| Investing Activities: | |||||||||||||||||
| Investments In Property Plant And Equipment
| -7,726.712 | -62,495.762 | -12,618.066 | -4,817.382 | -1,240.38 | -1,331.103 | -1,849.914 | -2,772.112 | -2,848.207 | -1,075.71 | -1,126.96 | -677.268 | -1,031.385 | -4,656.184 | -5,728.803 | -2,245.183 | -11,797.708 |
| Acquisitions Net
| 474.371 | 122.066 | 9.208 | 6,178.931 | 409.448 | 121.653 | 166.958 | 786.192 | 1,765.907 | 1,580.655 | 2,245.026 | 2,057.638 | 1,974.82 | 148.081 | -501.086 | 76.66 | -8.198 |
| Purchases Of Investments
| -115,426.075 | -22,599.488 | -4,714.748 | -26,536.863 | -60,493.852 | -48,020.103 | -13,100 | -7,000.3 | -33,247.358 | -5,688.087 | -90,097.368 | -44,537.15 | -55,549.232 | -0.39 | -78.69 | -50.895 | -77,959.107 |
| Sales Maturities Of Investments
| 73,330.399 | 27,948.577 | 25,992.59 | 24,322.596 | 39,291.317 | 34,180.078 | 15,372.8 | 53,321.503 | 30,180.954 | 60 | 88,761.232 | 60,277.398 | 55,049.789 | 1,324.071 | 14,231.303 | 36,884.206 | 76,380.472 |
| Other Investing Activites
| 20,645.941 | 323,850.517 | 1,764.15 | -263.714 | 0.15 | 209.49 | -86.957 | -64.23 | -42.256 | 230.399 | 5 | 129.888 | 505.434 | 121.183 | 399.412 | 190.441 | -277.942 |
| Investing Cash Flow
| -28,702.076 | 266,825.91 | 10,433.133 | -1,116.431 | -22,033.317 | -14,839.985 | 502.888 | 44,271.053 | -4,190.959 | -4,892.743 | -213.07 | 17,250.506 | 949.426 | -3,063.239 | 8,322.136 | 34,855.229 | -13,662.483 |
| Financing Activities: | |||||||||||||||||
| Debt Repayment
| -390.915 | 0 | -57.912 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7,300 | -3,500 | -3,000 | -4,300 | -2,000 | 0 | 0 |
| Common Stock Issued
| -653.279 | 0 | 0 | 0 | 15,855.291 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5,000 | 0 | 0 | 0 |
| Common Stock Repurchased
| -14,994.854 | -4,228.703 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,939.873 | -1,639.245 | -8,540.621 | -16,187.16 | -10,012.972 | -50,681.547 | -4,413.301 |
| Dividends Paid
| -29,656.64 | -1,150.326 | -1,150.326 | -1,150.326 | -1,007.826 | -1,007.826 | -1,007.826 | -1,007.826 | -671.884 | -335.942 | -410.591 | -694.85 | -750.395 | -915.833 | -995.687 | -1,310.783 | -1,329.75 |
| Other Financing Activities
| 1,172.745 | -357.227 | -273.065 | -285.495 | -117 | 0 | 0 | 0 | 0 | 0 | 5,800 | 1,500 | 1,500 | 0.001 | 5,000 | 0 | 0 |
| Financing Cash Flow
| -44,522.944 | -5,736.256 | -1,481.303 | -1,435.821 | 14,730.465 | -1,007.826 | -1,007.826 | -1,007.826 | -671.884 | -335.942 | -3,850.463 | -4,334.095 | -10,791.016 | -16,402.992 | -8,008.659 | -51,992.33 | -5,743.051 |
| Other Information: | |||||||||||||||||
| Effect Of Forex Changes On Cash
| 109.129 | -47.529 | -31.456 | -63.482 | -1.979 | 3.909 | -4.597 | 136.629 | 235.807 | 0.013 | -39.592 | -0 | 108.725 | 277.279 | 0 | 0 | 0 |
| Net Change In Cash
| -112,834.583 | 222,076.113 | 14,624.448 | -1,058.435 | -2,916.158 | -752.685 | 9,649.14 | 12,386.386 | 1,414.099 | -1,038.101 | 960.822 | 1,597.809 | -1,488.662 | -544.646 | 1,578.598 | -601.393 | -15,234.136 |
| Cash At End Of Period
| 160,085.707 | 272,920.29 | 50,844.178 | 36,219.73 | 37,278.164 | 1,391.931 | 29,521.99 | 19,872.85 | 7,486.464 | 6,072.365 | 7,110.466 | 6,149.644 | 4,551.835 | 6,040.497 | 6,585.143 | 5,006.545 | 5,607.938 |